Live Breaking News & Updates on Performance Officer Mitchell

Stay updated with breaking news from Performance officer mitchell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s vice president of investor relations, Nichol Ochsner. Nichol?
Nichol Ochsner
Vice President, Investor Relations
Good morning, everyone. Thank you for joining today to discuss our first-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results. The press release is available on the company s website therapeuticsmd.com and the Investors and Media section.
On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conferenc ....

Devin Geiman Guggenheim , Rob Finizio , Douglas Tsao , Robert Finizio , Mitchell Krassan , Louise Chen , Nichol Ochsner , James Darecca , Dana Flanders , Jen Kim Cantor Fitzgerald , Cantor Fitzgerald , Therapeuticsmd Inc , Chief Executive Officer Robert Finizio , Chief Financial Officer Jamesd Arecca , Chief Commercial Officer Dawn Halkuff , Chief Strategy , Performance Officer Mitchell , Medical Necessity , Affordable Care , Vagina Appreciation Day , Orange Book , Orange Book Listed , Long May She Reign , Jamesd Arecca , டக்ளஸ் ட்‌ஸ்ம் , லூயிஸ் சென் ,

TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s Vice President of Investor Relations Nichol Ochsner. Nichol?
Nichol Ochsner
Vice President, Investor Relations
Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our fourth-quarter financial results.
The press release is available on the company s website, therapeuticsmd.com in the investors and media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during t ....

Devin Geiman Guggenheim , Rob Finizio , Douglas Tsao , Whitney Cummings , Robert Finizio , Mitch Krassan , Mitchell Krassan , Louise Chen , Annabel Samimy , Nichol Ochsner , James Darecca , Dana Flanders , Louise Chen Cantor Fitzgerald , Pop Council , Annabel Samimy Stifel Financial Corp , Therapeuticsmd Inc , Investor Relations Nichol , Chief Executive Officer Robert Finizio , Chief Financial Officer Jamesd Arecca , Chief Commercial Officer Dawn Halkuff , Chief Strategy , Performance Officer Mitchell , Just Say , Performance Officer , Nuvaring Generic , Stifel Financial ,